Personal tools

Coexpression cluster:C3403

From FANTOM5_SSTAR

Revision as of 16:19, 12 September 2012 by Autoedit (talk | contribs)
Jump to: navigation, search


Full id: C3403_mixed_Smooth_Mesenchymal_peripheral_breast_gastric_anaplastic



Phase1 CAGE Peaks

Hg19::chr14:21101221..21101225,+p@chr14:21101221..21101225
+
Hg19::chr6:27198345..27198350,-p@chr6:27198345..27198350
-
Hg19::chr6:27198375..27198387,-p@chr6:27198375..27198387
-


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


No GOStat results

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br><br>disease_data<br>


Cell Type
Ontology termp-valuen
epithelial cell1.87e-11254
Disease
Ontology termp-valuen
cell type cancer1.92e-38143
cancer3.07e-38235
disease of cellular proliferation5.16e-38239
carcinoma4.78e-28106
organ system cancer6.79e-11137
adenocarcinoma2.57e-1025
germ cell and embryonal cancer2.45e-0922
germ cell cancer2.45e-0922


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


(#promoters = Number of promoters in this coexpression cluster that have ChIP signal of the TF)

TF#promotersEnrichmentp-valueq-value
BDP1#5581431050.153409090918.48810554071848e-107.96486302396314e-08
BRF1#297231777.182692307691.73053960074675e-101.81461672050592e-08
CEBPB#105137.971147625824820.001974187055288560.0115050567416596
EP300#203336.77394172622320.003216880500103790.0167156466764685
FOSL2#2355316.93020060456170.0002060162053171620.00242571888017126
FOXA1#3169311.08141974938550.000734755275698670.00580242769290687
FOXA2#3170216.42030916844350.004810682352105480.022582832352191
GTF2B#2959331.94382993432423.06634405746243e-050.00062670431901628
HDAC2#3066313.41562023662630.0004140761399857210.00390445088334856
HSF1#32973164.2906666666672.24910326529255e-071.19054280752098e-05
JUND#372736.994663941871030.002921845042734990.0156393283322161
MAFF#23764237.54357099329680.0009344774015560320.00676856129697693
MAFK#7975218.06715542521990.003983674744936810.019106820054487
POLR3A#111283339.1321100917432.54979953570819e-081.77295947876051e-06
POLR3G#1062232174.435294117659.38614178523023e-111.02006166691744e-08
TAF7#6879311.43306940492390.0006690181981945830.00541640244970884
TCF12#6938310.63446490218640.0008313523990202070.00628442481190441
USF1#739136.361499277207960.00388404057290560.0189864410668705



Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.